ArticleCPT: pharmacometrics & systems pharmacology2026

Correction to "Development of an Agent-Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec".

No numbers read from the abstract.

Not cited yet